Korea to Expand Research Funding to All Nine Regional National University Hospitals - Seoul Economic Daily

- South Korea is expanding its research and development support program from five to all nine regional national university hospitals, with a second phase beginning in 2028.
- The program funds advanced medical research including genomic big data analysis and whole-exome sequencing, which identifies mutations across all protein-coding regions of the genome.
- This expansion allows clinicians to turn patient treatment observations into active research projects, such as Jeju National University Hospital's infectious disease outbreak prediction model.
Sources & Citations
1 sourceMore Stories
Montana’s giving the biotech industry sweeping authority to sell unapproved drugs - POLITICO
• Montana is granting the biotech industry broad authority to sell unapproved drugs, allowing patients to access experimental treatments regardless of federal regulations. • The state's move bypasses the standard FDA process, which typically requires three phases of clinical trials to assess efficacy, dosage, and adverse events.
Read original · politico.comMorning Rounds: FDA hiring, Chris Clomp hearing, Ebola outbreak
• The FDA continues to face operational challenges and hiring freezes resulting from budget cuts implemented by the Department of Government Efficiency (DOGE). • These cuts have stymied the agency's ability to fill critical roles and maintain standard staffing levels.
Read original · statnews.com
StatnewsHealthcare news you need to know - NewsBreak
• Sarah Axelrath of the Colorado Coalition for the Homeless told the Denver City Council on Monday that targeting drug traffickers does not stop substance use. • Axelrath, an addiction medicine specialist, stated that these law enforcement actions disrupt an already potent and unpredictable drug supply.
Read original · newsbreak.comNew polls highlight tumbling trust in measles vaccine safety, advice from doctors
• Two new polls indicate a decline in global and U.S. trust regarding medical advice and the safety of the measles vaccine for children. • Only 19% of 1,143 adult respondents approved of President Donald Trump's handling of measles outbreaks, while 52% expressed disapproval.
Read original · cidrap.umn.eduPituitary Cancer Market to Grow at 9.4% CAGR Through 2033 as Personalized Cancer Care and Emerging Therapies Open New Growth Opportunities
• The pituitary cancer market is projected to expand at a compound annual growth rate of 9.4% between 2026 and 2033. • DataM Intelligence 4 Market Research LLP reports that the sector is shifting from a specialized oncology niche toward precision diagnosis and targeted treatments.
Read original · openpr.com
OpenPRAbortion bans make ‘evidence-based medicine’ impossible in some cases, new report says | Abortion
• The Society for Maternal-Fetal Medicine released a statement on Tuesday arguing that abortion care is a core component of maternal-fetal practice. • The report notes that 41 states currently ban abortion at some point during pregnancy.
Read original · theguardian.comWhat went right this week: the good news that matters - Positive News
• Researchers are launching a clinical trial to determine if the experimental drug trontinemab can prevent people with high p-tau217 levels from developing dementia. • The study aims to recruit 1,600 participants following previous research showing the drug cleared amyloid plaques, a hallmark of Alzheimer's, in 90% of early-stage patients.
Read original · positive.news
Positive NewsThird Measles Death in Pennsylvania as 693 Cases Spread and CDC Help Is Refused
• An unvaccinated 40-year-old woman in Jefferson County, Pennsylvania, died from measles complications in 2026. • Pennsylvania has recorded 693 confirmed cases across 38 counties and has refused the CDC Epi-Aid outbreak assistance that six other states requested.
Read original · easternherald.comUS push to cut drug prices could mean longer waits for European patients
• A new modelling study published in The Lancet suggests European patients may face longer waits for new medicines due to US efforts to lower drug prices. • Researchers analyzed 195 patented medicines that represent $87.9 billion of annual spending in the United States.
Read original · euronews.com
EuronewsClinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in ?DR Congo with 48% Crude Fatality Rate, Says NanoViricides
• NanoViricides will begin a Phase II clinical trial next week for NV-387, an oral gummy drug designed to treat the Bundibugyo Ebola virus. • The trial responds to an expanding outbreak in the Democratic Republic of Congo where the crude fatality rate has reached 48%.
Read original · investingnews.com
Investing News NetworkWHO expresses cautious optimism about bid to control Ebola outbreak in DRC
• The World Health Organization expressed cautious optimism regarding the trajectory of the current Ebola outbreak in the Democratic Republic of the Congo. • This event is the second largest Ebola outbreak on record, though overall case counts remain high.
Read original · statnews.com
Statnews